The expanding demand for controlled immunological study and therapeutic development has spurred significant advances in recombinant signal molecule generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently produced using diverse expression platforms, including bacterial hosts, higher cell populations, and HPI